Jin Medical International Ltd. has released its unaudited condensed consolidated financial results for the six months ended March 31, 2025. The company reported a net income of $8,998, down from $1.704 million in the same period the previous year. The comprehensive loss for the current period was $796,139, compared to a comprehensive income of $1.864 million in the prior year. This shift was significantly impacted by a foreign currency translation loss of $805,137, compared to a gain of $159,423 in the previous period. Earnings per share remained at $0.00, consistent with the previous period's $0.01. The weighted average shares outstanding were 156.547 million, slightly up from 156.401 million in the previous year. The company's main operations are located in the People's Republic of China, which could influence its business and financial condition due to the political, economic, and legal environments in the region. Jin Medical International Ltd. has not provided any specific outlook or guidance for future periods.